StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Contract liabilities by Year

Contract liabilities — Annual reimbursement cap contracts for CF medicines in ex-U.S. government markets ($M) ($M)

Vertex Pharmaceuticals Contract liabilities: $172M in FY2025, down 16.9% from a year earlier.

Latest, FY2025
172
Period ended Dec 31, 2025
Change on a year earlier
-16.9%
207 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

“We had contract liabilities of $ 157.0 million and $ 171.8 million as of June 30, 2026 and December 31, 2025 , respectively, primarily related to annual contracts with government-owned and supported customers in international markets that limit the amount of annual reimbursement we can receive for our CF products.”

Source: Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Revenue Note (Contract Liabilities under International Annual Cap Contracts).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedContract liabilities — Annual reimbursement cap contracts for CF medicines in ex-U.S. government markets ($M) ($M)Year on yearSource
FY2025Dec 31, 2025172-16.9%Form 10-Q (vrtx-20260630.htm, filed 2026-08-04) ↗
FY2024Dec 31, 2024207+21.4%Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
FY2023Dec 31, 2023170+6.7%Form 10-K (vrtx-20241231.htm, filed 2025-02-13) ↗
FY2022Dec 31, 2022160-7.0%Form 10-K (vrtx-20231231.htm, filed 2024-02-15) ↗
FY2021Dec 31, 2021172-10.3%Form 10-K (vrtx-20221231.htm, filed 2023-02-10) ↗
FY2020Dec 31, 2020192+207.4%Form 10-K (vrtx-20211231.htm, filed 2022-02-09) ↗
FY2019Dec 31, 201962.3+150.2%Form 10-K (vrtx-20201231.htm, filed 2021-02-11) ↗
FY2018Dec 31, 201824.9–Form 10-K (a201910k-main.htm, filed 2020-02-13) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Contract liabilities ($M), annual FY2018–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/intl-cf-cap-contract-liab

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.